DRGEM Corporation (KOSDAQ:263690)
5,180.00
+10.00 (0.19%)
At close: Oct 2, 2026
DRGEM Market Cap
DRGEM has a market cap or net worth of 56.44 billion as of October 2, 2026. Its market cap has decreased by -11.45% in one year.
Market Cap
56.44B
Enterprise Value
49.82B
Revenue
109.45B
Ranking
n/a
PE Ratio
4.60
Stock Price
5,180.00
ChartMarket Cap Chart
Since November 22, 2018, DRGEM's market cap has decreased from 76.56B to 56.44B, a decrease of -26.28%. That is a compound annual growth rate of -3.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 56.44B | -3.00% |
| Dec 30, 2025 | 58.18B | -6.54% |
| Dec 30, 2024 | 62.26B | -45.72% |
| Dec 28, 2023 | 114.68B | -1.79% |
| Dec 29, 2022 | 116.78B | -13.05% |
| Dec 30, 2021 | 134.30B | -29.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| L&K Biomed | 132.10B |
| Hironic | 80.49B |
| Remed | 77.81B |
| SELVAS Healthcare | 69.69B |
| Dynamic solution | 55.26B |
| QuantaMatrix | 46.41B |
| JPI Healthcare | 45.28B |
| Genoray | 42.14B |